ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
- 28 July 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (30), 12465-12470
- https://doi.org/10.1073/pnas.0905931106
Abstract
Chromosomal rearrangements involving erythroblast transformation specific (ETS) family transcription factors were recently defined as the most common genetic alterations in human prostate cancer. Despite their prevalence, it is unclear what quantitative role they play in either initiation or progression of the disease. Using a lentiviral transduction and dissociated cell prostate regeneration approach, we find that acutely increased expression of ETS proteins in adult murine prostate epithelial cells is sufficient to induce the formation of epithelial hyperplasia and focal prostatic intraepithelial neoplasia (PIN) lesions, but not progression to carcinoma. However, combined expression of ERG with additional genetic alternations associated with human prostate cancer can lead to aggressive disease. Although ERG overexpression does not cooperate with loss of the tumor suppressor p53, it does collaborate with alterations in PI3K signaling, such as Pten knockdown or AKT up-regulation, to produce a well-differentiated adenocarcinoma. Most striking is our finding that overexpression of androgen receptor (AR) does not give rise to any hyperplastic lesions, but when combined with high levels of ERG, it promotes the development of a more poorly differentiated, invasive adenocarcinoma. These findings suggest that in human prostate cancer, the most potent function of ETS gene fusions may be to synergize with alternative genetic events and provide different pathways for carcinoma production and invasive behavior. Our results provide direct evidence for selective cooperating events in ERG-induced prostate tumorigenesis and offer a rational basis for combined therapeutic interventions against multiple oncogenic pathways in prostate cancer.Keywords
This publication has 46 references indexed in Scilit:
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisNature Genetics, 2009
- ETS rearrangements and prostate cancer initiationNature, 2009
- Pleiotropic functional properties of androgen receptor mutants in prostate cancerHuman Mutation, 2008
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- Recurrent gene fusions in prostate cancerNature Reviews Cancer, 2008
- Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen ReceptorCancer Cell, 2007
- Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptorProceedings of the National Academy of Sciences of the United States of America, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006
- Cancer genes and the pathways they controlNature Medicine, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003